Home / News / India News / Article /
SII manufacturing first batch of Covovax Covid-19 vaccine, says Poonawalla
Updated On: 25 June, 2021 12:00 AM IST | Pune | PTI
In March this year, he had said that the clinical trials of Covovax vaccine have begun in India and the company hopes to launch it by September this year.
Listen to this article :
Representational Image | File Pic
The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India’s Pune facility, SII CEO Adar Poonawalla said on Friday.
Excited to witness the first batch of Covovax (developed by @Novavax) being manufactured this week at our facility in Pune. The vaccine has great potential to protect our future generations below the age of 18. Trials are ongoing. Well done team @seruminstindia! pic.twitter.com/K4YzY6o73A
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT